PT  - JOURNAL ARTICLE
AU  - Neftali Watkinson
AU  - Tony Givargis
AU  - Victor Joe
AU  - Alexandru Nicolau
AU  - Alexander Veidenbaum
TI  - Class-Modeling of Septic Shock With Hyperdimensional Computing
AID  - 10.1101/2021.05.21.21257481
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.21.21257481
4099  - http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257481.short
4100  - http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257481.full
AB  - Sepsis arises when a patient’s immune system has an extreme reaction to an infection. This is followed by septic shock if damage to organ tissue is so extensive that it causes a total systemic failure. Early detection of septic shock among septic patients could save critical time for preparation and prevention treatment. Due to the high variance in symptoms and patient state before shock, it is challenging to create a protocol that would be effective across patients. However, since septic shock is an acute change in patient state, modeling patient stability could be more effective in detecting a condition that departs from it. In this paper we present a one-class classification approach to septic shock using hyperdimensional computing. We built various models that consider different contexts and can be adapted according to a target priority. Among septic patients, the models can detect septic shock accurately with 90% sensitivity and overall accuracy of 60% of the cases up to three hours before the onset of septic shock, with the ability to adjust predictions according to incoming data. Additionally, the models can be easily adapted to prioritize sensitivity (increase true positives) or specificity (decrease false positives).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received in support of this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the datasets that were used are publicly available and deidentified.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data we used for our models is available through the resources we cite in the paper.